Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $379.0K | $2.8M | $0 | $50.0K | $54.0K | $23.0K | $0 | $1.3M |
| Cost of revenue | $13.0K | $100.0K | $0 | $2.0K | $2.0K | $0 | $0 | $682.0K |
| Gross profit | $366.0K | $2.7M | $0 | $48.0K | $52.0K | $23.0K | $0 | $654.0K |
| Gross margin | 96.6% | 96.5% | — | 96.0% | 96.3% | 100.0% | — | 49.0% |
| R&D | $19.2M | $19.6M | $21.1M | $22.6M | $26.4M | $21.6M | $30.1M | $14.0M |
| Operating income | −$25.3M | −$23.3M | −$28.0M | −$33.7M | −$35.5M | −$29.5M | −$50.6M | −$23.3M |
| EBITDA | −$22.6M | −$21.1M | −$25.6M | −$24.1M | −$33.6M | −$27.4M | −$48.4M | −$22.1M |
| Net income | −$24.7M | −$23.2M | −$27.8M | −$26.1M | −$35.3M | −$29.2M | −$49.9M | −$23.3M |
| Net margin | -6511.1% | -816.5% | — | -52252.0% | -65383.3% | -126747.8% | — | -1740.3% |
| EPS (diluted) | -3.51 | -2.92 | -3.18 | -2.47 | -2.86 | -1.60 | -1.77 | -3.56 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds PSTI.
No tracked institution reports a position in PSTI as of their last filing.
No one on the platform has traded PSTI yet.
| $45M |
| — |
| LIANYLianBio | $0.12 | -28.13% | $13M | — |
| LUMOLumos Pharma, Inc. | $4.34 | +0.00% | $38M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.